Systematic review / meta-analysis / 2019
Higher dietary intake of total phytosterols and campestanol was linked to a lower risk of cancer in a meta-analysis of observational studies.
A systematic review and meta-analysis of 11 case-control and case-cohort studies evaluated the relationship between dietary phytosterols and cancer risk. Comparing highest versus lowest intake, the summary relative risk was 0.63 (95% CI = 0.49-0.81) for total phytosterols and 0.77 (95% CI = 0.65-0.90) for campestanol. Relative risks for other phytosterols were 0.74 (95% CI = 0.54-1.02) for β-sitosterol, 0.72 (95% CI = 0.51-1.00) for campesterol, 0.83 (95% CI = 0.60-1.16) for stigmasterol, and 1.12 (95% CI = 0.96-1.32) for β-sitostanol. Dose-response analyses indicated a linear association for campesterol and a nonlinear association for total phytosterols.
Shows an association, not proof of cause and effect.
- Study type
- Systematic review and meta-analysis of observational studies
- Who was studied
- Participants across 11 case-control and case-cohort studies
- What was measured
- Cancer risk
THE PAPER
The Protective Effect of Dietary Phytosterols on Cancer Risk: A Systematic Meta-Analysis.
Jiang L, Zhao X, Xu J, Li C, Yu Y, Wang W, Zhu L. J Oncol, 2019.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.